U.S. markets closed
  • S&P 500

    4,594.62
    -106.84 (-2.27%)
     
  • Dow 30

    34,899.34
    -905.06 (-2.53%)
     
  • Nasdaq

    15,491.66
    -353.54 (-2.23%)
     
  • Russell 2000

    2,245.94
    -85.52 (-3.67%)
     
  • Crude Oil

    68.17
    -10.22 (-13.04%)
     
  • Gold

    1,788.10
    +1.20 (+0.07%)
     
  • Silver

    23.14
    -0.40 (-1.70%)
     
  • EUR/USD

    1.1328
    +0.0116 (+1.03%)
     
  • 10-Yr Bond

    1.4820
    -0.1630 (-9.91%)
     
  • GBP/USD

    1.3315
    -0.0004 (-0.03%)
     
  • USD/JPY

    113.4080
    -1.9310 (-1.67%)
     
  • BTC-USD

    53,788.10
    -1,044.68 (-1.91%)
     
  • CMC Crypto 200

    1,365.60
    -89.81 (-6.17%)
     
  • FTSE 100

    7,044.03
    -266.34 (-3.64%)
     
  • Nikkei 225

    28,751.62
    -747.66 (-2.53%)
     

Kindred Bio: 1Q Earnings Snapshot

BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Thursday reported a loss of $16.1 million in its first quarter.

On a per-share basis, the Burlingame, California-based company said it had a loss of 42 cents.

The biopharmaceutical company posted revenue of $515,000 in the period.

Kindred Bio shares have dropped 18% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $8.97, a decline of 7% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KIN at https://www.zacks.com/ap/KIN